Thus, heightened CD40 signaling through the combination of chronic CD154 expression and CD22-deficiency drove the in vivo expansion of regulatory B10 cells with functional activity, and limited the intensity of IgG immune responses, both of which may limit the pathogenic consequences of autoimmunity. The gene discussed is CD40; the disease is Autoimmunity.